MindWalk Holdings Corp. (HYFT) stock
HYFTNasdaqPharmaceutical PreparationsFiscal year ends April 30
$0.90−0.01 (-0.74%)
Close on Nov 18, 2026Market cap $42.04MP/E –Yield –
MindWalk revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
MindWalk's revenue for the twelve months ending Jul 31, 2026 was C$16.23M, up 43.4% year over year. For fiscal 2026 it was C$15.56M, up 46.4% from the year before. The highest annual figure on record is C$20.67M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | C$15.56M | +46.4% |
| FY2025 | Apr 30, 2025 | C$10.63M | +3.4% |
| FY2024 | Apr 30, 2024 | C$10.28M | -50.3% |
| FY2023 | Apr 30, 2023 | C$20.67M | +6.7% |
| FY2022 | Apr 30, 2022 | C$19.36M | +8.1% |
| FY2021 | Apr 30, 2021 | C$17.91M | +27.4% |
| FY2020 | Apr 30, 2020 | C$14.06M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | C$3.83M | +21.3% |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | C$4.12M | +49.8% |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | C$4.16M | +52.4% |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | C$4.12M | +53.9% |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | C$3.16M | +27.8% |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | C$2.75M | -57.5% |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | C$2.73M | -56.1% |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | C$2.68M | -56.4% |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | C$2.47M | -56.5% |
| Q4 FY2024CQ1 2024 | Apr 30, 2024 | C$6.46M | +14.9% |
| Q3 FY2024CQ4 2023 | Jan 31, 2024 | C$6.22M | +20.3% |
| Q2 FY2024CQ3 2023 | Oct 31, 2023 | C$6.15M | +18.6% |
| Q1 FY2024CQ2 2023 | Jul 31, 2023 | C$5.69M | – |
| Q4 FY2023CQ1 2023 | Apr 30, 2023 | C$5.62M | – |
| Q3 FY2023CQ4 2022 | Jan 31, 2023 | C$5.17M | – |
| Q2 FY2023CQ3 2022 | Oct 31, 2022 | C$5.18M | – |
See a number that looks wrong?